|
시장보고서
상품코드
1544267
세계의 비흑색종 피부암 시장(2024-2028년)Global Non-melanoma Skin Cancer Market 2024-2028 |
||||||
비흑색종 피부암(NMSC) 시장은 2023-20281년에 1억 3,690만 달러, 예측 기간 중 CAGR은 4.5%로 성장할 것으로 예측됩니다.
비흑색종 피부암 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개의 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 NMSC 보도와 지원, 피부암에 관한 인지도의 향상, 조직에 의한 구상의 확대가 촉진하고 있습니다.
| 시장 범위 | |
|---|---|
| 기준년 | 2024 |
| 종료년 | 2028 |
| 예측 기간 | 2024-2028 |
| 성장 모멘텀 | 가속 |
| 전년대비 2024년 | 4.22% |
| CAGR | 4.5% |
| 증분액 | 1억 3,690만 달러 |
본 조사에서는 향후 수년간 비흑색종 피부암 시장 성장을 촉진하는 주요인의 하나로 NMSC의 이환율 증가를 들고 있습니다. 또한 수술이 NMSC의 1차 치료법이라고 생각되고 있는 것 및 NMSC에 대한 국소 치료의 적응외 사용이 많은 것도 시장의 큰 수요로 연결될 것으로 생각됩니다.
목차
제1장 개요
- 시장 개요
제2장 시장 구도
- 시장 에코시스템
- 시장의 특징
- 밸류체인 분석
제3장 시장 규모 평가
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2023
- 시장 전망 2023-2028
제4장 시장 규모 실적
- 세계의 비흑색종 피부암 시장 2018-2022
- 유형별 부문 분석 2018-2022
- 지역별 부문 분석 2018-2022
- 국가별 부문 분석 2018-2022
제5장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제6장 시장 세분화 : 유형별
- 시장 세분화
- 비교 : 유형별
- BCC(기저세포암) : 시장 규모와 예측 2023-2028
- SCC(유극세포암) : 시장 규모와 예측 2023-2028
- 시장 기회 : 유형별
제7장 고객 상황
- 고객 상황의 개요
제8장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2023-2028
- 유럽 : 시장 규모와 예측 2023-2028
- 아시아 : 시장 규모와 예측 2023-2028
- 세계의 기타 지역 : 시장 규모와 예측 2023-2028
- 미국 : 시장 규모와 예측 2023-2028
- 캐나다 : 시장 규모와 예측 2023-2028
- 영국 : 시장 규모와 예측 2023-2028
- 독일 : 시장 규모와 예측 2023-2028
- 일본 : 시장 규모와 예측 2023-2028
- 중국 : 시장 규모와 예측 2023-2028
- 시장 기회 : 지역 상황별
제9장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제10장 경쟁 구도
- 개요
- 경쟁 구도
- 혼란 상황
- 업계의 리스크
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Almirall SA
- Bausch Health Companies Inc.
- Bristol Myers Squibb Co.
- Elekta AB
- F. Hoffmann La Roche Ltd.
- Sun Pharmaceutical Industries Ltd.
- Varian Medical Systems Inc.
- Viatris Inc.
- Vidac Pharma
제12장 부록
KSA 24.09.11The non-melanoma skin cancer market is forecasted to grow by USD 136.9 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the non-melanoma skin cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by NMSC coverage and support, increase in awareness about skin cancer, and growing initiatives by organizations.
Technavio's non-melanoma skin cancer market is segmented as below:
| Market Scope | |
|---|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 4.22% |
| CAGR | 4.5% |
| Incremental Value | $136.9 mn |
By Type
- BCC
- SCC
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing incidence of NMSC as one of the prime reasons driving the non-melanoma skin cancer market growth during the next few years. Also, surgery considered as first-line curative approach for NMSC and high off-label use of topical treatments for NMSC will lead to sizable demand in the market.
The report on the non-melanoma skin cancer market covers the following areas:
- Non-melanoma skin cancer market sizing
- Non-melanoma skin cancer market forecast
- Non-melanoma skin cancer market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-melanoma skin cancer market vendors that include 3M Co., Almirall SA, Amgen Inc., Bausch Health Companies Inc., Bristol Myers Squibb Co., Elekta AB, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, iCAD Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sensus Healthcare Inc., Sun Pharmaceutical Industries Ltd., Varian Medical Systems Inc., Viatris Inc., and Vidac Pharma. Also, the non-melanoma skin cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Non-Melanoma Skin Cancer Market 2018 - 2022
- Historic Market Size - Data Table on Global Non-Melanoma Skin Cancer Market 2018 - 2022 ($ million)
- 4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
- 6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 6.3 BCC - Market size and forecast 2023-2028
- Chart on BCC - Market size and forecast 2023-2028 ($ million)
- Data Table on BCC - Market size and forecast 2023-2028 ($ million)
- Chart on BCC - Year-over-year growth 2023-2028 (%)
- Data Table on BCC - Year-over-year growth 2023-2028 (%)
- 6.4 SCC - Market size and forecast 2023-2028
- Chart on SCC - Market size and forecast 2023-2028 ($ million)
- Data Table on SCC - Market size and forecast 2023-2028 ($ million)
- Chart on SCC - Year-over-year growth 2023-2028 (%)
- Data Table on SCC - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 8.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 8.12 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 8.13 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- Companies covered
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 3M Co.
- 3M Co. - Overview
- 3M Co. - Business segments
- 3M Co. - Key news
- 3M Co. - Key offerings
- 3M Co. - Segment focus
- 11.4 Almirall SA
- Almirall SA - Overview
- Almirall SA - Product / Service
- Almirall SA - Key news
- Almirall SA - Key offerings
- 11.5 Bausch Health Companies Inc.
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key news
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- 11.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 11.7 Elekta AB
- Elekta AB - Overview
- Elekta AB - Business segments
- Elekta AB - Key offerings
- Elekta AB - Segment focus
- 11.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 11.9 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- 11.10 Varian Medical Systems Inc.
- Varian Medical Systems Inc. - Overview
- Varian Medical Systems Inc. - Product / Service
- Varian Medical Systems Inc. - Key offerings
- 11.11 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- 11.12 Vidac Pharma
- Vidac Pharma - Overview
- Vidac Pharma - Product / Service
- Vidac Pharma - Key offerings
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- Research methodology
- 12.5 Data procurement
- Information sources
- 12.6 Data validation
- Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
- List of abbreviations
